ASX - By Stock
|
PER |
Re:
ANP presenting now
|
|
Vinceanna
|
183 |
76K |
8 |
12/04/21 |
12/04/21 |
ASX - By Stock
|
183
|
76K
|
8
|
|
ASX - By Stock
|
PER |
Re:
ANP presenting now
|
|
Vinceanna
|
183 |
76K |
7 |
12/04/21 |
12/04/21 |
ASX - By Stock
|
183
|
76K
|
7
|
|
ASX - By Stock
|
PER |
Re:
ANP presenting now
|
|
Vinceanna
|
183 |
76K |
38 |
11/04/21 |
11/04/21 |
ASX - By Stock
|
183
|
76K
|
38
|
|
ASX - By Stock
|
PER |
Re:
ANP presenting now
|
|
Vinceanna
|
183 |
76K |
7 |
10/04/21 |
10/04/21 |
ASX - By Stock
|
183
|
76K
|
7
|
|
Charts
|
PER |
Re:
Chart
|
|
Vinceanna
|
5.9K |
2.3M |
20 |
10/04/21 |
10/04/21 |
Charts
|
5.9K
|
2.3M
|
20
|
|
Charts
|
PER |
Re:
Chart
|
|
Vinceanna
|
5.9K |
2.3M |
17 |
08/04/21 |
08/04/21 |
Charts
|
5.9K
|
2.3M
|
17
|
|
Charts
|
PER |
Re:
Chart
|
|
Vinceanna
|
5.9K |
2.3M |
9 |
07/04/21 |
07/04/21 |
Charts
|
5.9K
|
2.3M
|
9
|
|
Charts
|
PER |
Re:
Chart
|
|
Vinceanna
|
5.9K |
2.3M |
14 |
07/04/21 |
07/04/21 |
Charts
|
5.9K
|
2.3M
|
14
|
|
Charts
|
PER |
Re:
Chart
|
|
Vinceanna
|
5.9K |
2.3M |
4 |
07/04/21 |
07/04/21 |
Charts
|
5.9K
|
2.3M
|
4
|
|
ASX - By Stock
|
PER |
Re:
US deal for ATL1102
|
|
Vinceanna
|
202 |
74K |
13 |
07/04/21 |
07/04/21 |
ASX - By Stock
|
202
|
74K
|
13
|
|
ASX - By Stock
|
PER |
Re:
US deal for ATL1102
|
|
Vinceanna
|
202 |
74K |
5 |
06/04/21 |
06/04/21 |
ASX - By Stock
|
202
|
74K
|
5
|
|
ASX - By Stock
|
PER |
Re:
US deal for ATL1102
|
|
Vinceanna
|
202 |
74K |
15 |
06/04/21 |
06/04/21 |
ASX - By Stock
|
202
|
74K
|
15
|
|
ASX - By Stock
|
PER |
Re:
ANP presenting now
|
|
Vinceanna
|
183 |
76K |
7 |
06/04/21 |
06/04/21 |
ASX - By Stock
|
183
|
76K
|
7
|
|
ASX - By Stock
|
PER |
Re:
ANP presenting now
|
|
Vinceanna
|
183 |
76K |
13 |
05/04/21 |
05/04/21 |
ASX - By Stock
|
183
|
76K
|
13
|
|
ASX - By Stock
|
PER |
Re:
Could the immune system be key to Alzheimer’s disease?
|
|
Vinceanna
|
14 |
10K |
24 |
05/04/21 |
05/04/21 |
ASX - By Stock
|
14
|
10K
|
24
|
|
ASX - By Stock
|
PER |
Re:
Could the immune system be key to Alzheimer’s disease?
|
|
Vinceanna
|
14 |
10K |
29 |
03/04/21 |
03/04/21 |
ASX - By Stock
|
14
|
10K
|
29
|
|
ASX - By Stock
|
PER |
Re:
Could the immune system be key to Alzheimer’s disease?
|
|
Vinceanna
|
14 |
10K |
21 |
02/04/21 |
02/04/21 |
ASX - By Stock
|
14
|
10K
|
21
|
|
Charts
|
PER |
Re:
Chart
|
|
Vinceanna
|
5.9K |
2.3M |
7 |
01/04/21 |
01/04/21 |
Charts
|
5.9K
|
2.3M
|
7
|
|
ASX - By Stock
|
PER |
Re:
ANP presenting now
|
|
Vinceanna
|
183 |
76K |
21 |
31/03/21 |
31/03/21 |
ASX - By Stock
|
183
|
76K
|
21
|
|
ASX - By Stock
|
PER |
Re:
ANP presenting now
|
|
Vinceanna
|
183 |
76K |
14 |
30/03/21 |
30/03/21 |
ASX - By Stock
|
183
|
76K
|
14
|
|
ASX - By Stock
|
PER |
Re:
ANP presenting now
|
|
Vinceanna
|
183 |
76K |
29 |
29/03/21 |
29/03/21 |
ASX - By Stock
|
183
|
76K
|
29
|
|
ASX - By Stock
|
PER |
Re:
ANP presenting now
|
|
Vinceanna
|
183 |
76K |
9 |
29/03/21 |
29/03/21 |
ASX - By Stock
|
183
|
76K
|
9
|
|
ASX - By Stock
|
PER |
Re:
ANP presenting now
|
|
Vinceanna
|
183 |
76K |
2 |
28/03/21 |
28/03/21 |
ASX - By Stock
|
183
|
76K
|
2
|
|
ASX - By Stock
|
PER |
Re:
ANP presenting now
|
|
Vinceanna
|
183 |
76K |
9 |
28/03/21 |
28/03/21 |
ASX - By Stock
|
183
|
76K
|
9
|
|
ASX - By Stock
|
PER |
Re:
ANP presenting now
|
|
Vinceanna
|
183 |
76K |
22 |
28/03/21 |
28/03/21 |
ASX - By Stock
|
183
|
76K
|
22
|
|
ASX - By Stock
|
PER |
Re:
US deal for ATL1102
|
|
Vinceanna
|
202 |
74K |
12 |
27/03/21 |
27/03/21 |
ASX - By Stock
|
202
|
74K
|
12
|
|
ASX - By Stock
|
PER |
Re:
ANP presenting now
|
|
Vinceanna
|
183 |
76K |
29 |
27/03/21 |
27/03/21 |
ASX - By Stock
|
183
|
76K
|
29
|
|
ASX - By Stock
|
PER |
Re:
ANP presenting now
|
|
Vinceanna
|
183 |
76K |
9 |
26/03/21 |
26/03/21 |
ASX - By Stock
|
183
|
76K
|
9
|
|
ASX - By Stock
|
PER |
Re:
Think & reflect
|
|
Vinceanna
|
8 |
3.5K |
6 |
25/03/21 |
25/03/21 |
ASX - By Stock
|
8
|
3.5K
|
6
|
|
ASX - By Stock
|
PER |
Re:
Think & reflect
|
|
Vinceanna
|
8 |
3.5K |
8 |
24/03/21 |
24/03/21 |
ASX - By Stock
|
8
|
3.5K
|
8
|
|
Charts
|
PER |
Re:
Chart
|
|
Vinceanna
|
5.9K |
2.3M |
27 |
24/03/21 |
24/03/21 |
Charts
|
5.9K
|
2.3M
|
27
|
|
ASX - By Stock
|
PER |
Re:
Ann: Antisense Therapeutics appoints new Non-Executive Director
|
|
Vinceanna
|
37 |
13K |
16 |
22/03/21 |
22/03/21 |
ASX - By Stock
|
37
|
13K
|
16
|
|
ASX - By Stock
|
PER |
Re:
Ann: Antisense Therapeutics appoints new Non-Executive Director
|
|
Vinceanna
|
37 |
13K |
5 |
22/03/21 |
22/03/21 |
ASX - By Stock
|
37
|
13K
|
5
|
|
ASX - By Stock
|
PER |
Re:
Ann: Antisense Therapeutics appoints new Non-Executive Director
|
|
Vinceanna
|
37 |
13K |
24 |
22/03/21 |
22/03/21 |
ASX - By Stock
|
37
|
13K
|
24
|
|
Charts
|
PER |
Re:
Chart
|
|
Vinceanna
|
5.9K |
2.3M |
12 |
21/03/21 |
21/03/21 |
Charts
|
5.9K
|
2.3M
|
12
|
|
Charts
|
PER |
Re:
Chart
|
|
Vinceanna
|
5.9K |
2.3M |
2 |
20/03/21 |
20/03/21 |
Charts
|
5.9K
|
2.3M
|
2
|
|
ASX - By Stock
|
PER |
Re:
Ann: FDA Rare Disease Day 2021
|
|
Vinceanna
|
31 |
13K |
10 |
20/03/21 |
20/03/21 |
ASX - By Stock
|
31
|
13K
|
10
|
|
Charts
|
PER |
Re:
Chart
|
|
Vinceanna
|
5.9K |
2.3M |
3 |
19/03/21 |
19/03/21 |
Charts
|
5.9K
|
2.3M
|
3
|
|
Charts
|
PER |
Re:
Chart
|
|
Vinceanna
|
5.9K |
2.3M |
10 |
19/03/21 |
19/03/21 |
Charts
|
5.9K
|
2.3M
|
10
|
|
Charts
|
PER |
Re:
Chart
|
|
Vinceanna
|
5.9K |
2.3M |
2 |
19/03/21 |
19/03/21 |
Charts
|
5.9K
|
2.3M
|
2
|
|
ASX - By Stock
|
PER |
Re:
Sarepta gene therapy study missed key target in Duchennes
|
|
Vinceanna
|
413 |
166K |
20 |
18/03/21 |
18/03/21 |
ASX - By Stock
|
413
|
166K
|
20
|
|
ASX - By Stock
|
PER |
Re:
Sarepta gene therapy study missed key target in Duchennes
|
|
Vinceanna
|
413 |
166K |
20 |
18/03/21 |
18/03/21 |
ASX - By Stock
|
413
|
166K
|
20
|
|
ASX - By Stock
|
PER |
Re:
ANP Presentation
|
|
Vinceanna
|
37 |
11K |
11 |
17/03/21 |
17/03/21 |
ASX - By Stock
|
37
|
11K
|
11
|
|
ASX - By Stock
|
PER |
Re:
ANP Presentation
|
|
Vinceanna
|
37 |
11K |
7 |
16/03/21 |
16/03/21 |
ASX - By Stock
|
37
|
11K
|
7
|
|
ASX - By Stock
|
PER |
Re:
ANP Presentation
|
|
Vinceanna
|
37 |
11K |
9 |
16/03/21 |
16/03/21 |
ASX - By Stock
|
37
|
11K
|
9
|
|
ASX - By Stock
|
PER |
Re:
ANP Presentation
|
|
Vinceanna
|
37 |
11K |
1 |
16/03/21 |
16/03/21 |
ASX - By Stock
|
37
|
11K
|
1
|
|
ASX - By Stock
|
PER |
ANP Presentation
|
|
Vinceanna
|
37 |
11K |
9 |
15/03/21 |
15/03/21 |
ASX - By Stock
|
37
|
11K
|
9
|
|
ASX - By Stock
|
PER |
Re:
Sarepta gene therapy study missed key target in Duchennes
|
|
Vinceanna
|
413 |
166K |
9 |
14/03/21 |
14/03/21 |
ASX - By Stock
|
413
|
166K
|
9
|
|
Charts
|
PER |
Re:
Chart
|
|
Vinceanna
|
5.9K |
2.3M |
4 |
14/03/21 |
14/03/21 |
Charts
|
5.9K
|
2.3M
|
4
|
|
Charts
|
PER |
Re:
Chart
|
|
Vinceanna
|
5.9K |
2.3M |
7 |
14/03/21 |
14/03/21 |
Charts
|
5.9K
|
2.3M
|
7
|
|